Anaptysbio (ANAB) Non Operating Income (2016 - 2026)
Anaptysbio (ANAB) reported Non Operating Income of -$1000.0 for Q1 2026, down 100.05% on a YoY basis from $1.9 million in Q1 2025, and down 100.0% quarter-over-quarter from $49.2 million in Q4 2025.
Anaptysbio (ANAB) Non Operating Income (2016 - 2026) Analysis & Trends
Anaptysbio has reported Non Operating Income for 11 years, with the latest figure at -$1000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 100.05% year-over-year to -$1000.0; the trailing twelve-month figure through Mar 2026 stood at $52.7 million (up 615.68% YoY), and the FY2025 full-year result was $5.4 million, up 117.93% from the prior year.
- Non Operating Income for Q1 2026 stood at -$1000.0, down from $49.2 million in the prior quarter.
- The five-year high for Non Operating Income was $49.2 million in Q4 2025, with the low at -$12.1 million in Q4 2024.
- Historically, Non Operating Income has averaged $2.2 million across 5 years, with a median of -$1000.0 in 2026.
- Annual changes were most pronounced in 2023 — Non Operating Income jumped 4866.67% — and 2024, when it tumbled 605900.0%.
- Anaptysbio's Non Operating Income stood at -$4000.0 in 2022, then jumped by 50.0% to -$2000.0 in 2023, then plunged by 605900.0% to -$12.1 million in 2024, then surged by 505.84% to $49.2 million in 2025, then tumbled by 100.0% to -$1000.0 in 2026.
- The last three Non Operating Income figures came in at -$1000.0 (Q1 2026), $49.2 million (Q4 2025), and $3.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | 49.19 Mn |
| Jun 30, 2025 | 3.53 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | -12.12 Mn |
| Sep 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -1.74 Mn |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 298,000.00 |
| Mar 31, 2023 | 146,000.00 |
| Dec 31, 2022 | -4,000.00 |
| Sep 30, 2022 | -3.87 Mn |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | -4.51 Mn |
| Dec 31, 2021 | -362,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Mar 31, 2021 | 198,000.00 |
| Dec 31, 2020 | -75,000.00 |
| Sep 30, 2020 | -56,000.00 |